Although it has been suggested that vasopressin (VP) acts within the central nervous system to modulate autonomic cardiovascular controls, the mechanisms involved are not understood. Using nonpeptide, selective V 1a, V1b, and V2 antagonists, in conscious rats, we assessed the roles of central VP receptors, under basal conditions, after the central application of exogenous VP, and after immobilization, on cardiovascular short-term variability. Equidistant sampling of blood pressure (BP) and heart rate (HR) at 20 Hz allowed direct spectral analysis in very-low frequency (VLF-BP), low-frequency (LF-BP), and highfrequency (HF-BP) blood pressure domains. The effect of VP antagonists and of exogenous VP on body temperature (Tb) was also investigated. Under basal conditions, V 1a antagonist increased HF-BP and Tb, and this was prevented by metamizol. V1b antagonist enhanced HF-BP without affecting Tb, and V2 antagonist increased VLF-BP variability which could be prevented by quinapril. Immobilization increased BP, LF-BP, HF-BP, and HF-HR variability. V1a antagonist prevented BP and HR variability changes induced by immobilization and potentiated tachycardia. V1b antagonist prevented BP but not HR variability changes, whereas V2 antagonist had no effect. Exogenous VP increased systolic arterial pressure (SAP) and HF-SAP variability, and this was prevented by V1a and V1b but not V2 antagonist pretreatment. Our results suggest that, under basal conditions, VP, by stimulation of V1a, V1b, and cognate V2 receptors, buffers BP variability, mostly due to thermoregulation. Immobilization and exogenous VP, by stimulation of V1a or V1b, but not V2 receptors, increases BP variability, revealing cardiorespiratory adjustment to stress and respiratory stimulation, respectively. temperature; heart rate; V1a; V1b; V2 antagonist VASOPRESSIN (VP) IS A NEUROHYPOPHYSEAL peptide that acts both as neurohormone and central neurotransmitter/modulator. Peripherally, VP exerts a variety of biological effects in mammals: body fluid balance, blood pressure (BP) control, platelet aggregation, ACTH, aldosterone and clothing factor VIII secretion, liver glycogenolysis, and uterine motility. Centrally, VP affects learning, memory, behavior, and autonomic functions such as BP, body temperature (T b ), and respiration. The role of VP is particularly important in stress (14,25,27), and VP dysfunction was found to contribute to the pathogenesis of cardiovascular disease (28, 35) and to underlie central diabetes insipidus.So far, three types of G protein-linked membrane-bound VP receptor subtypes, V 1a , V 1b , and V 2 , have been cloned and characterized by their primary structure, gene localization, mRNA distribution, physiological function, and pharmacology (4,12,41,47). V 2 receptors have been found only in the periphery; they are positively coupled to adenylcyclase and play a dominant role in the antidiuretic response to VP. V 1a and V 1b receptors have been found both peripherally and in the central nervous system (CNS), where they mediate phospholi...